ConductScience.org, home

Paper64575

Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92.

Glode MP and 5 others. J Infect Dis, 1977. Cited by 77 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. Papers, record 64575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/64575

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92.
PubMed
Journal
J Infect Dis
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
77
iCite
Relative citation ratio, by iCite
2.58
iCite
Revised in PubMed
2019-05-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Glode MPM P
2Robbins JBJ B
3Liu TYT Y
4Gotschlich ECE C
5Orskov II
6Orskov FF

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, BacterialMajor topic
Cross ReactionsMajor topic
Escherichia coliMajor topic
Neisseria meningitidisMajor topic
Polysaccharides, BacterialMajor topic
Adult
Animals
Child
Child, Preschool
Epitopes
Humans
Immunodiffusion
Infant
Rabbits

Source PubMed

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.

PMIDTitleJournalYearIn PapersSource
41,986,986Hemolytic Uremic Syndrome Outbreak in Adults and Shiga Toxin-Producing Escherichia coli Negative for Locus of Enterocyte Effacement, France, 2025.Emerg Infect Dis2026https://conductscience.org/library/papers/41986986PubMed
40,086,461
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial.
Lancet2025https://conductscience.org/library/papers/40086461PubMed
32,418,063The epidemiology of invasive meningococcal disease and the utility of vaccination in Malta.Eur J Clin Microbiol Infect Dis2020https://conductscience.org/library/papers/32418063PubMed
30,611,213Use of saliva to monitor meningococcal vaccine responses: proposing a threshold in saliva as surrogate of protection.BMC Med Res Methodol2019https://conductscience.org/library/papers/30611213PubMed
28,724,897X-ray crystallographic structure of a bacterial polysialyltransferase provides insight into the biosynthesis of capsular polysialic acid.Sci Rep2017https://conductscience.org/library/papers/28724897PubMed
27,593,883Immunogenicity of MenACWY-CRM in Korean Military Recruits: Influence of Tetanus-Diphtheria Toxoid Vaccination on the Vaccine Response to MenACWY-CRM.Yonsei Med J2016https://conductscience.org/library/papers/27593883PubMed
24,372,337Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules.FEMS Microbiol Rev2014https://conductscience.org/library/papers/24372337PubMed
23,032,159
Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers.
Hum Vaccin Immunother2012https://conductscience.org/library/papers/23032159PubMed
22,038,849Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood.Clin Vaccine Immunol2011https://conductscience.org/library/papers/22038849PubMed
18,535,032Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study.BMJ2008https://conductscience.org/library/papers/18535032PubMed
15,385,492Naturally acquired passive protective activity against Neisseria meningitidis Group C in the absence of serum bactericidal activity.Infect Immun2004https://conductscience.org/library/papers/15385492PubMed
12,454,147Direct and rapid identification and genogrouping of meningococci and porA amplification by LightCycler PCR.J Clin Microbiol2002https://conductscience.org/library/papers/12454147PubMed
11,748,199Neisserial immunoglobulin A1 protease induces specific T-cell responses in humans.Infect Immun2002https://conductscience.org/library/papers/11748199PubMed
10,225,908Cellular immune responses to Neisseria meningitidis in children.Infect Immun1999https://conductscience.org/library/papers/10225908PubMed
9,784,556Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.Infect Immun1998https://conductscience.org/library/papers/9784556PubMed
7,729,901Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain.Infect Immun1995https://conductscience.org/library/papers/7729901PubMed
6,811,434Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine.Infect Immun1982https://conductscience.org/library/papers/6811434PubMed
6,354,922Opsonization of various capsular (K) E. coli by the alternative complement pathway.Immunology1983https://conductscience.org/library/papers/6354922PubMed
6,345,392
Purification and immunochemical properties of Escherichia coli B polysaccharide cross-reacting with Salmonella typhi Vi antigen: preliminary evidence for cross-reaction of the polysaccharide with Escherichia coli K1 antigen.
Infect Immun1983https://conductscience.org/library/papers/6345392PubMed
6,166,415Immunological cross-reaction between a naturally occurring galactan, agarose, and an LPS locus for immune lysis of Neisseria meningitidis by human sera.Clin Exp Immunol1981https://conductscience.org/library/papers/6166415PubMed

See all 30 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/64575

GET https://conductscience.org/api/papers/v1/64575/cited_by?page=2